- Home
- MGRX vs ICCM Comparison
MGRX vs ICCM Comparison
Compare MGRX & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MGRX | ICCM |
|---|---|---|
| Founded | 2021 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1M | 8.3M |
| IPO Year | 2023 | 2013 |
Fundamental Metrics
Financial Performance| Metric | MGRX | ICCM |
|---|---|---|
| Price | $0.47 | $2.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | ★ 428.3K | 92.8K |
| Earning Date | 05-14-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $456,021.00 | N/A |
| Revenue This Year | N/A | $139.51 |
| Revenue Next Year | N/A | $75.66 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.26 | $0.13 |
| 52 Week High | $2.75 | $9.54 |
Technical Indicators
Market Signals| Indicator | MGRX | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 55.15 | 36.77 |
| Support Level | $0.34 | $0.22 |
| Resistance Level | $0.47 | $2.50 |
| Average True Range (ATR) | 0.03 | 0.14 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 81.03 | 21.82 |
Price Performance
Historical ComparisonAbout MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.